Locations
Boston, MA, USA · West Street / River Street, Boston, MA, USA
industry
Biotechnology · Data and Analytics · DeepTech · Health · Software
Size
11-50 employees
Stage
Series A
founded in
2020
Nabla Bio is focused on advancing drug design through the integration of AI-guided antibody design and experimental technologies. The company develops generative models and multiplexed screening methods to create antibodies for challenging disease targets, partnering with leading pharmaceutical companies to enhance drug manufacturability, safety, and efficacy. With a strong technical team and a commitment to empirical measurement, Nabla aims to unlock new therapeutic opportunities in the pharmaceutical industry.
Something looks off?On-site & Remote